Cross-linking cellular prion protein triggers neuronal apoptosis in vivo

被引:281
作者
Solforosi, L
Criado, JR
McGavern, DB
Wirz, S
Sánchez-Alavez, M
Sugama, S
DeGiorgio, LA
Volpe, BT
Wiseman, E
Abalos, G
Masliah, E
Gilden, D
Oldstone, MB
Conti, B
Williamson, RA
机构
[1] Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA
[2] Scripps Res Inst, Dept Neuropharmacol, La Jolla, CA 92037 USA
[3] Scripps Res Inst, Harold Dorris Neurol Res Ctr, La Jolla, CA 92037 USA
[4] Cornell Univ, Weill Med Coll, Burke Med Res Inst, Dept Neurol & Neurosci, White Plains, NY 10605 USA
[5] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92037 USA
[6] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92037 USA
[7] Univ Colorado, Dept Neurol, Denver, CO 80262 USA
关键词
D O I
10.1126/science.1094273
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Neuronal death is a prominent, but poorly understood, pathological hallmark of prion disease. Notably, in the absence of the cellular prion protein (PrPC), the disease-associated isoform, PrPSc, appears not to be intrinsically neurotoxic, suggesting that PrPC itself may participate directly in the prion neurodegenerative cascade. Here, cross-linking PrPC in vivo with specific monoclonal antibodies was found to trigger rapid and extensive apoptosis in hippocampal and cerebellar neurons. These findings suggest that PrPC functions in the control of neuronal survival and provides a model to explore whether cross-linking of PrPC by oligomeric PrPSc can promote neuronal loss during prion infection.
引用
收藏
页码:1514 / 1516
页数:3
相关论文
共 14 条
  • [1] Normal host prion protein necessary for scrapie-induced neurotoxicity
    Brandner, S
    Isenmann, S
    Raeber, A
    Fischer, M
    Sailer, A
    Kobayashi, Y
    Marino, S
    Weissmann, C
    Aguzzi, A
    [J]. NATURE, 1996, 379 (6563) : 339 - 343
  • [2] BURTON D, 1987, MOL GENETICS IMMUNOG
  • [3] Prion diseases: What is the neurotoxic molecule?
    Chiesa, R
    Harris, DA
    [J]. NEUROBIOLOGY OF DISEASE, 2001, 8 (05) : 743 - 763
  • [4] Prion diseases of humans and animals: Their causes and molecular basis
    Collinge, J
    [J]. ANNUAL REVIEW OF NEUROSCIENCE, 2001, 24 : 519 - 550
  • [5] Complement C5a receptor-mediated signaling may be involved in neurodegeneration in Alzheimer's disease
    Farkas, I
    Takahashi, M
    Fukuda, A
    Yamamoto, N
    Akatsu, H
    Baranyi, L
    Tateyama, H
    Yamamoto, T
    Okada, N
    Okada, H
    [J]. JOURNAL OF IMMUNOLOGY, 2003, 170 (11) : 5764 - 5771
  • [6] Prevention of scrapie pathogenesis by transgenic expression of anti-prion protein antibodies
    Heppner, FL
    Musahl, C
    Arrighi, I
    Klein, MA
    Rülicke, T
    Oesch, B
    Zinkernagel, RM
    Kalinke, U
    Aguzzi, A
    [J]. SCIENCE, 2001, 294 (5540) : 178 - 182
  • [7] Mutant and infectious prion proteins display common biochemical properties in cultured cells
    Lehmann, S
    Harris, DA
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (03) : 1633 - 1637
  • [8] Depleting neuronal PrP in prion infection prevents disease and reverses spongiosis
    Mallucci, G
    Dickinson, A
    Linehan, J
    Klöhn, PC
    Brandner, S
    Collinge, J
    [J]. SCIENCE, 2003, 302 (5646) : 871 - 874
  • [9] Signal transduction through prion protein
    Mouillet-Richard, S
    Ermonval, M
    Chebassier, C
    Laplanche, JL
    Lehmann, S
    Launay, JM
    Kellermann, O
    [J]. SCIENCE, 2000, 289 (5486) : 1925 - 1928
  • [10] Antibodies inhibit prion propagation and clear cell cultures of prion infectivity
    Peretz, D
    Williamson, RA
    Kaneko, K
    Vergara, J
    Leclerc, E
    Schmitt-Ulms, G
    Mehlhorn, IR
    Legname, G
    Wormald, MR
    Rudd, PM
    Dwek, RA
    Burton, DR
    Prusiner, SB
    [J]. NATURE, 2001, 412 (6848) : 739 - 743